Nektar Therapeutics has two Phase IIb studies underway for rezpeg in atopic dermatitis and severe alopecia areata, with read-outs expected in 1H'25. Success in either indication would significantly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback